Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?

Fig. 1

French map with estimated mean annual regional incidence rates of Lyme disease (per 100 000 inhabitants) and incidence of cetuximab-induced hypersensitivity infusion reactions (CI-IRs) in each of the four French areas

CI-IRs, cetuximab-induced hypersensitivity infusion reactions; N, number of patients

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us